Yüklüyor......
Idiopathic Thrombocytopenic Purpura: A Rare Syndrome with Alemtuzumab, Review of Monitoring Protocol
Alemtuzumab, a humanized monoclonal antibody that targets surface molecule CD52, causes rapid and complete depletion of circulating T- and B-lymphocytes through antibody-dependent cell-mediated and complement-mediated cytotoxicity. Alemtuzumab has demonstrated superior efficacy compared to subcutane...
Kaydedildi:
| Yayımlandı: | Cureus |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cureus
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823085/ https://ncbi.nlm.nih.gov/pubmed/31720183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5715 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|